Novocure Ltd buy melinda
Start price
06.03.18
/
50%
€19.62
Target price
17.04.18
€21.29
Performance (%)
8.85%
End price
17.04.18
€21.35
Summary
This prediction ended on 17.04.18 with a price of €21.35. With a performance of 8.85%, the BUY prediction by melinda for Novocure Ltd closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novocure Ltd | 3.488% | 3.488% | -54.591% | -86.197% |
| iShares Core DAX® | 2.331% | 5.140% | 25.000% | 65.619% |
| iShares Nasdaq 100 | 2.077% | 2.956% | 8.935% | 111.545% |
| iShares Nikkei 225® | 2.759% | 7.214% | 22.171% | 56.683% |
| iShares S&P 500 | 1.613% | 2.893% | 6.249% | 68.722% |
Comments by melinda for this prediction
In the thread Novocure Ltd diskutieren
Biotechnologie und Medizintechnik SecteurRecherche Agenda 14/05 Ergebnisse Veröffentlichung
$ 21.75
+0,15 (+ 0,69%) Tumor Behandlung Fields (TTFields) - PANOVA 3 Bauchspeicheldrüsenkrebs
Phase 3 2022 2022.12.31 Phase-3-Daten im Jahr 2022 fällig.